Compare CATX & CTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CATX | CTO |
|---|---|---|
| Founded | 1983 | 1902 |
| Country | United States | United States |
| Employees | N/A | 42 |
| Industry | Medical/Dental Instruments | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 497.9M | 599.1M |
| IPO Year | 2018 | N/A |
| Metric | CATX | CTO |
|---|---|---|
| Price | $4.24 | $19.67 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 2 |
| Target Price | $12.11 | ★ $21.50 |
| AVG Volume (30 Days) | ★ 1.2M | 183.7K |
| Earning Date | 05-11-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 7.80% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $7.63 |
| Revenue Next Year | N/A | $2.76 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.75 | $15.07 |
| 52 Week High | $6.16 | $20.25 |
| Indicator | CATX | CTO |
|---|---|---|
| Relative Strength Index (RSI) | 43.31 | 65.46 |
| Support Level | $3.17 | $17.14 |
| Resistance Level | $4.64 | $19.82 |
| Average True Range (ATR) | 0.27 | 0.31 |
| MACD | 0.01 | 0.13 |
| Stochastic Oscillator | 53.75 | 98.81 |
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
CTO Realty Growth Inc is a real estate investment trust company, that owns income properties in diversified markets in the United States. The company operates in four primary business segments: Income properties, management services, commercial loans and investments, and real estate operations. It derives maximum revenue from Income Properties.